These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
947 related articles for article (PubMed ID: 17721103)
1. Risk of cancers during interrupted antiretroviral therapy in the SMART study. Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103 [TBL] [Abstract][Full Text] [Related]
2. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death. Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD; HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766 [TBL] [Abstract][Full Text] [Related]
3. AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era. Silverberg MJ; Abrams DI Curr Opin Oncol; 2007 Sep; 19(5):446-51. PubMed ID: 17762569 [TBL] [Abstract][Full Text] [Related]
4. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic. Ives NJ; Gazzard BG; Easterbrook PJ J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320 [TBL] [Abstract][Full Text] [Related]
5. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S; J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006 [TBL] [Abstract][Full Text] [Related]
6. CD4+ guided antiretroviral treatment interruption in HIV infection: a meta-analysis. Seminari E; De Silvestri A; Boschi A; Tinelli C AIDS Rev; 2008; 10(4):236-44. PubMed ID: 19092979 [TBL] [Abstract][Full Text] [Related]
7. Ten years later: a single hospital experience with malignancy in HIV/AIDS. Reed M; Cosgrove JM; Cindrich R; Parithivel VS; Gad Y; Bangalore M; Uzor R; Kalim J; Segura R; Albu E J Surg Oncol; 2010 Sep; 102(3):282-6. PubMed ID: 20740588 [TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038 [TBL] [Abstract][Full Text] [Related]
9. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
10. The growing problem of non-AIDS-defining malignancies in HIV. Pantanowitz L; Schlecht HP; Dezube BJ Curr Opin Oncol; 2006 Sep; 18(5):469-78. PubMed ID: 16894295 [TBL] [Abstract][Full Text] [Related]
11. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002. Bedimo R; Chen RY; Accortt NA; Raper JL; Linn C; Allison JJ; Dubay J; Saag MS; Hoesley CJ Clin Infect Dis; 2004 Nov; 39(9):1380-4. PubMed ID: 15494916 [TBL] [Abstract][Full Text] [Related]
12. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. Wolbers M; Bucher HC; Furrer H; Rickenbach M; Cavassini M; Weber R; Schmid P; Bernasconi E; Hirschel B; Battegay M; HIV Med; 2008 Jul; 9(6):397-405. PubMed ID: 18410354 [TBL] [Abstract][Full Text] [Related]
13. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; ChĂȘne G; Morlat P Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829 [TBL] [Abstract][Full Text] [Related]
15. Less cancer--or more--with HAART? Or, reflections on a late opus. Mascolini M J Int Assoc Physicians AIDS Care; 1998 Jun; 4(6):12-22. PubMed ID: 11365531 [TBL] [Abstract][Full Text] [Related]
17. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Cheung MC; Pantanowitz L; Dezube BJ Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835 [TBL] [Abstract][Full Text] [Related]
18. HIV infection and cancer in the era of highly active antiretroviral therapy (Review). Barbaro G; Barbarini G Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054 [TBL] [Abstract][Full Text] [Related]
19. Evolving epidemiology of malignancies in HIV. Bonnet F; ChĂȘne G Curr Opin Oncol; 2008 Sep; 20(5):534-40. PubMed ID: 19106656 [TBL] [Abstract][Full Text] [Related]
20. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study. Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT; Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]